Yüklüyor......
Raltitrexed Inhibits HepG2 Cell Proliferation via G(0)/G(1) Cell Cycle Arrest
Raltitrexed (RTX) is an antimetabolite drug used as a chemotherapeutic agent for treating colorectal cancer, malignant mesothelioma, and gastric cancer. The antitumor capacity of RTX is attributed to its inhibitory activity on thymidylate synthase (TS), a key enzyme in the synthesis of DNA precursor...
Kaydedildi:
| Yayımlandı: | Oncol Res |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cognizant Communication Corporation
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7838684/ https://ncbi.nlm.nih.gov/pubmed/27098147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504016X14562725373671 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|